Core Viewpoint - Church & Dwight reported strong fourth-quarter earnings that surpassed analyst expectations, leading to a 4% increase in share price intraday [1] Financial Performance - Adjusted earnings per share were $0.86, exceeding the consensus estimate of $0.84 [1] - Revenue reached $1.64 billion, aligning with expectations and reflecting a year-over-year increase of 3.9% [1] - Organic sales grew by 0.7%, improving to 1.8% when excluding the divested vitamin business [1] Margin and Cost Management - Adjusted gross margin expanded by 90 basis points to 45.5%, outperforming expectations [2] - Margin improvement was attributed to productivity initiatives, higher volumes, and a favorable product mix, which countered inflationary and tariff-related pressures [2] Strategic Decisions - The company completed the sale of its vitamin brands VITAFUSION and L'IL CRITTERS, incurring a one-time after-tax charge of $45.6 million [3] - The board approved a 4.2% increase in the quarterly dividend to $0.3075 per share, marking the 30th consecutive year of dividend growth [3] Future Outlook - For 2026, the company forecasts organic sales growth of 3% to 4% and adjusted EPS growth of 5% to 8% [4] - For the first quarter of 2026, organic sales growth is projected at approximately 3%, with adjusted EPS expected to be $0.92, slightly higher than the previous year [4]